Drug Profile
RG 7863
Alternative Names: RG7863; RO 6870868Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 01 Mar 2017 Adverse events, pharmacodynamic and pharmacokinetics data from a phase I trial in Hepatitis B presented at The Liver Meeting 2016: 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2016)
- 24 Jul 2014 Discontinued - Phase-I for Hepatitis B (In volunteers) in Netherlands (unspecified route)
- 01 Aug 2013 Phase-I clinical trials in Hepatitis B (In volunteers) in Netherlands (unspecified route) (NCT01911611)